Cymabay Therapeu Buy Hold or Sell Recommendation
| CBAYDelisted Stock | USD 11.83 0.27 2.34% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Cymabay Therapeu is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Cymabay Therapeu given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Cymabay Therapeu, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. In addition, we conduct extensive research on individual companies such as Cymabay and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Cymabay Therapeu. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Cymabay |
Execute Cymabay Therapeu Buy or Sell Advice
The Cymabay recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cymabay Therapeu. Macroaxis does not own or have any residual interests in Cymabay Therapeu or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cymabay Therapeu's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Cymabay Therapeu Trading Alerts and Improvement Suggestions
| Cymabay Therapeu is not yet fully synchronised with the market data | |
| Cymabay Therapeu has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 31.07 M. Net Loss for the year was (105.37 M) with loss before overhead, payroll, taxes, and interest of (41.63 M). | |
| Cymabay Therapeu currently holds about 153.42 M in cash with (72.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.81. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies |
Cymabay Therapeu Returns Distribution Density
The distribution of Cymabay Therapeu's historical returns is an attempt to chart the uncertainty of Cymabay Therapeu's future price movements. The chart of the probability distribution of Cymabay Therapeu daily returns describes the distribution of returns around its average expected value. We use Cymabay Therapeu price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cymabay Therapeu returns is essential to provide solid investment advice for Cymabay Therapeu.
| Mean Return | 0.40 | Value At Risk | -5.47 | Potential Upside | 6.85 | Standard Deviation | 5.83 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cymabay Therapeu historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 49245 shares by Robert Wills of Cymabay Therapeu at 4.05 subject to Rule 16b-3 [view details]
Cymabay Therapeu Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cymabay . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cymabay Therapeu Buy or Sell Advice
When is the right time to buy or sell Cymabay Therapeu? Buying financial instruments such as Cymabay Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cymabay Therapeu in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Blend Funds Thematic Idea Now
Small Blend Funds
Fund or Etfs that invest in stocks of small to mid-sized entities that have characteristics of both growth and value companies. The Small Blend Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Cymabay Stock
If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |